Globeflex Capital’s Epizyme, Inc EPZM Stock Holding History

Globeflex Capital’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-93	Closed	-$3K	–	697
2013 Q3	$3K	Buy	+93	New	+$3.15K	﹤0.01%	407

Other funds holding EPZM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Globeflex Capital's EPZM Position: Q4 2013 in Review

Globeflex Capital sold out of Epizyme, Inc (EPZM) in Q4 2013, closing a stake of 93 shares — an estimated $3K sold.

Globeflex Capital first reported a position in EPZM in Q3 2013 and held it in 1 quarter. The position peaked at $3K in Q3 2013. 60 funds tracked by Wall St. Rank hold EPZM as of Q4 2013.

Globeflex Capital reported no remaining Epizyme, Inc position as of Q4 2013 after selling out during the quarter.
Globeflex Capital sold 93 Epizyme, Inc shares in Q4 2013, an estimated $3K.
Globeflex Capital first reported a position in Epizyme, Inc in Q3 2013 and held it in 1 quarter.
Globeflex Capital's Epizyme, Inc position peaked at $3K in Q3 2013.
60 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2013.

Based on Globeflex Capital's 13F filing for Q4 2013, filed 12 Feb 2014.